Preservision

Added: Apr 20, 2017 12:59 pm PRE-SOLICITATION NOTICE:  The National Acquisition Center intends to enter into a sole-source contract with Bausch & Lomb for the procurement of PreserVision AREDS Lutein and AREDS2 Formula. PreserVision AREDS Lutein and AREDS2 formula are used for macular degeneration and cannot be therapeutically substituted with other ocular nutrition supplements. PreserVision AREDS Lutein and AREDS2 is a branded over-the-counter eye supplement with no generic alternative. At this time PreserVision AREDS Lutein and AREDS2 formula are the only supplements with the exact combination studied in the Age-Related Eye Disease Study (AREDS) recommended to slow progression to advanced macular degeneration. This action is to contract for the identified drug which is currently sourced from a non-designated Trades Agreement Act (TAA) country. The product is available from only one source, Bausch & Lomb. This notice of intent is not a request for competitive proposals. It is anticipated a contract will be awarded for a base plus four one-year options. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to: Richard.Mahario@va.gov  

The estimated annual requirements are as follows:

Description       Size   Estimated Annual Requirements



Preservation ARED Bottles of 50 Capsules 90,718

With Lutein



Preservation ARED 2 Bottles of 120 Capsules 379,131